Immunome Revenue

Biotechnology Research • Bothell, Washington, United States • 101-200 Employees

Immunome revenue & valuation

Annual revenue	$12,600,000
Revenue per employee	$72,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$40,300,000
Total funding	$505,000,000

Key Contact at Immunome

Philip Tsai

Chief Technology Officer

Mobile @immunome.com

Company overview

Headquarters	18702 North Creek Pkwy, 100, Bothell, Washington 98011, US
Phone number	+16103213700
Websites	immunome.com immunomeinc.com
NAICS	541714
SIC	873
Keywords	Biotechnology
Employees	101-200
Socials

Immunome Email Formats

Immunome uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@immunome.com), used 48.3% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@immunome.com	48.3%
{first name}{last name}	johndoe@immunome.com	45.6%
{last name}{last name}	doedoe@immunome.com	6.1%

About Immunome

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Director

Senior

Entry

Employees by Department

Immunome has 97 employees across 13 departments.

Departments

Number of employees

Funding Data

Explore Immunome's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-07-29	14	$125,000,000
2024-03-13	14	$230,000,000
2025-03-01	14	$150,000,000

Funding Insights

$505,000,000

Total funding amount

$150,000,000

Most recent funding amount

Number of funding rounds

Immunome Tech Stack

Discover the technologies and tools that power Immunome's digital infrastructure, from frameworks to analytics platforms.

Adobe Fonts

Font scripts

Twitter Emoji

Font scripts

SiteGround

Hosting

UserWay

Accessibility

Google Tag Manager

Tag managers

jQuery

JavaScript libraries

Nginx

Reverse proxies

PHP

Programming languages

Open Graph

Miscellaneous

WordPress

Blogs

Google Analytics

Analytics

Moove GDPR Consent

Cookie compliance

Frequently asked questions

Immunome is located in Bothell, Washington, US.

You can reach Immunome at +16103213700.

Immunome generates an estimated annual revenue of $12,589,000. This revenue figure reflects the company's market position and business performance in its industry.

Immunome has an estimated valuation of $40,300,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Immunome has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Immunome has raised a total of $505,000,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Immunome

Philip Tsai

Chief Technology Officer

Mobile @immunome.com

4.8

40,000 users